Topics

FDA aims to drive competition on the insulin market

12:53 EDT 2 Apr 2019 | Drug Store News
pharmacy/fda-aims-to-drive-competition-on-the-insulin-market/">

The FDA announced a public hearing to advance access to insulin products, including biosimilar and interchangeable insulin products.

Read More

Original Article: FDA aims to drive competition on the insulin market

NEXT ARTICLE

More From BioPortfolio on "FDA aims to drive competition on the insulin market"

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...